Early versus late hospital arrival for acute myocardial infarction in the western Washington thrombolytic therapy trials
References (25)
- et al.
Western Washington Intravenous Streptokinase in Myocardial Infarction Trial: radionuclide ventricular function and infarct size
JACC
(1988) - et al.
Factors contributing to delay in responding to the signs and symptoms of acute myocardial infarction
Am J Cardiol
(1969) - et al.
Delay in hospitalization during the acute coronary period
Am J Cardiol
(1969) - et al.
Basic emergency medical care of patients with acute myocardial infarction: initial pre-hospital characteristics and in-hospital complications
JACC
(1984) - et al.
Increased fatality and difficult diagnosis of in-hospital acute myocardial infarction: comparison to lower mortality and more easily recognized prehospital infarction
Am Heart J
(1981) - et al.
The prehospital course of patients with chest pain
Am J Med
(1978) - et al.
Coronary heart disease mortality: a community perspective
JAMA
(1972) - et al.
Reasons chest pain patients delay or do not call 911
Circulation
(1988) Effectiveness of intravenous thrombolytic therapy in acute myocardial infarction
Lancet
(1986)A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): mortality, morbidity, and infarct size at 21 days
N Engl J Med
(1986)
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected myocardial infarction: ISIS-2
Lancet
Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction
N Engl J Med
Cited by (85)
Knowledge and attitudes toward seeking medical care for AMI-symptoms
2011, International Journal of CardiologyCitation Excerpt :The first few hours are of utmost importance for limiting infarction size and to prevent cardiac death in patients with acute myocardial infarction (AMI) [1–3].
Usefulness of quantitative baseline ST-segment elevation for predicting outcomes after primary coronary angioplasty or fibrinolysis (results from the DANAMI-2 trial)
2006, American Journal of CardiologyCitation Excerpt :One reason could be that these patients had a larger amount of jeopardized myocardium and thus greater pain that urged them to seek medical care sooner compared with patients with less myocardial involvement. In accordance with this reasoning, patients with poor left ventricular function and a resulting higher mortality risk have been shown to have a tendency to seek help soon after symptom onset.17,18 Another possibility is that these patients, for whatever reason, presented sooner and that the degree of ST↑ reflected an earlier stage of MI.
Cardiac markers protocols in a chest pain observation unit
2001, Emergency Medicine Clinics of North AmericaCitation Excerpt :Serial sampling of cardiac markers over time is necessary to improve the detection of AMI in over 98% of cases. The time from symptom onset to presentation, which is critical to the interpretation of serum marker results, has been reported to be on average 2 to 6.5 hours.13,61 Recent data from the NRMI database and GUSTO I, however, place the mean time from symptom onset until presentation at 1.5 and 2 hours, respectively.51,69
Chest pain centers: Moving toward proactive acute coronary care
2000, International Journal of CardiologyREACT theory-based intervention to reduce treatment-seeking delay for acute myocardial infarction
1999, American Journal of Preventive Medicine